Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Archives of Endocrinology and Metabolism
|
January 18, 2023
Very low HDL levels: clinical assessment and management
Isabella Bonilha, Beatriz Luchiari, Wilson Nadruz, et al.
Journal of Clinical Medicine
|
June 2, 2021
Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
Isabella Bonilha, Francesca Zimetti, Ilaria Zanotti, et al.
Metabolites
|
December 23, 2021
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
Isabella Bonilha, Eric Hajduch, Beatriz Luchiari, et al.
International Journal of Molecular Sciences
|
January 27, 2024
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction
Helison R P Carmo, Isabella Bonilha, Joaquim Barreto, et al.
Biomedical Engineering Online
|
September 15, 2019
Heart defibrillation: relationship between pacing threshold and defibrillation probability
Priscila C Antoneli, Jair T Goulart, Isabella Bonilha, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
April 13, 2021
Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta-analyses
Andrei C Sposito, Isabella Bonilha, Beatriz Luchiari, et al.
Frontiers in Cardiovascular Medicine
|
May 16, 2022
Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
Luiz Sergio Fernandes de Carvalho, Ana Claudia Cavalcante Nogueira, Isabella Bonilha, et al.
Atherosclerosis
|
March 10, 2026
LDL subspecies and lipidome change by evolocumab add-on therapy to empagliflozin in patients with type 2 diabetes: A prespecified secondary analysis of a randomized clinical trial
Isabella Bonilha, Marcos Yukio Yoshinaga, Adriano Britto Chaves-Filho, et al.
Health Economics Review
|
October 25, 2023
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
Ana Claudia Cavalcante Nogueira, Joaquim Barreto, Filipe A Moura, et al.
Atherosclerosis
|
December 25, 2018
Adverse interaction between HDL and the mass of myocardial infarction
Alexandre A S Soares, Luiz Sergio F Carvalho, Isabella Bonilha, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Archives of Endocrinology and Metabolism
|
January 18, 2023
Very low HDL levels: clinical assessment and management
Isabella Bonilha, Beatriz Luchiari, Wilson Nadruz, et al.
Journal of Clinical Medicine
|
June 2, 2021
Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
Isabella Bonilha, Francesca Zimetti, Ilaria Zanotti, et al.
Metabolites
|
December 23, 2021
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
Isabella Bonilha, Eric Hajduch, Beatriz Luchiari, et al.
International Journal of Molecular Sciences
|
January 27, 2024
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction
Helison R P Carmo, Isabella Bonilha, Joaquim Barreto, et al.
Biomedical Engineering Online
|
September 15, 2019
Heart defibrillation: relationship between pacing threshold and defibrillation probability
Priscila C Antoneli, Jair T Goulart, Isabella Bonilha, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
April 13, 2021
Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta-analyses
Andrei C Sposito, Isabella Bonilha, Beatriz Luchiari, et al.
Frontiers in Cardiovascular Medicine
|
May 16, 2022
Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
Luiz Sergio Fernandes de Carvalho, Ana Claudia Cavalcante Nogueira, Isabella Bonilha, et al.
Atherosclerosis
|
March 10, 2026
LDL subspecies and lipidome change by evolocumab add-on therapy to empagliflozin in patients with type 2 diabetes: A prespecified secondary analysis of a randomized clinical trial
Isabella Bonilha, Marcos Yukio Yoshinaga, Adriano Britto Chaves-Filho, et al.
Health Economics Review
|
October 25, 2023
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
Ana Claudia Cavalcante Nogueira, Joaquim Barreto, Filipe A Moura, et al.
Atherosclerosis
|
December 25, 2018
Adverse interaction between HDL and the mass of myocardial infarction
Alexandre A S Soares, Luiz Sergio F Carvalho, Isabella Bonilha, et al.
Page
of 3